CORRESP Filing
Allarity Therapeutics, Inc.
Date: April 22, 2026 · CIK: 0001860657 · Accession: 0001213900-26-046485
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293420
Letter
Re: Allarity Therapeutics, Inc.
VIA EDGAR
April 22, 2026
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-3
File No. 333-293420
Acceleration Request
Requested Date: April 24, 2026
Requested Time: 4:00 p.m., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Allarity Therapeutics, Inc. (the “Company”) hereby requests the Securities and Exchange Commission take appropriate action to cause the above-referenced registration statement (the “Registration Statement”) to become effective on April 24, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Venable LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Venable LLP, by calling William N. Haddad at (212) 503-9812 or, in his absence, Arif Soto at (212) 503-0874.
Very truly yours,
ALLARITY THERAPEUTICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
VIA EDGAR
April 22, 2026
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Allarity Therapeutics,
Inc.
Registration Statement on Form S-3
File No. 333-293420
Acceleration Request
Requested Date: April
24, 2026
Requested Time: 4:00 p.m., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act
of 1933, as amended (the “Act”), Allarity Therapeutics, Inc. (the “Company”) hereby requests the Securities and
Exchange Commission take appropriate action to cause the above-referenced registration statement (the “Registration Statement”)
to become effective on April 24, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel,
Venable LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration
request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective,
please orally confirm the event with our counsel, Venable LLP, by calling William N. Haddad at (212) 503-9812 or, in his absence, Arif
Soto at (212) 503-0874.
Very truly yours,
ALLARITY THERAPEUTICS, INC.
By:
/s/ Thomas H. Jensen
Name:
Thomas H. Jensen
Title:
Chief Executive Officer
cc: William N. Haddad, Venable LLP
Arif Soto, Venable LLP